Transgene SA (TNG.PA) Stock Price
€0.61 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Transgene SA, AI stock picks, stock alerts and much more.
TNG.PA AI Stock Analysis
AI stock analysis for TNG.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Transgene SA (TNG.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Transgene SA (TNG.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Transgene SA (TNG.PA), currently trading at €0.61, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About TNG.PA
-
Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases.
-
Symbol
TNG.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
80.5M
Similar Stocks
 |
Valneva SE VLA.PA |
€3.04 1.1% |
5 |
 |
Financière de Tubize SA TUB.BR |
€110.2 1.3% |
6 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.9 1% |
7 |
 |
UCB SA UCB.BR |
€136.3 1.5% |
4 |
 |
Innate Pharma S.A. IPH.PA |
€1.75 0.5% |
4 |
News
No news articles.
TNG.PA Alternative Data
Web Traffic
Transgene SA receives an estimated 4674 monthly visitors to transgene.fr.
-
Web Traffic
4674
-
Change from Previous Month
40.5%
-
3 Month Change
22.3%
-
YoY Change
22.3%
News Mentions
Transgene SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Transgene SA has 1,606 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.2% over the last month.
-
Twitter Followers
1606
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
1.2%
Youtube Subscribers
Transgene SA has 65 subscribers on its main Youtube channel, up by 3.2% over the last month.
-
Youtube Subscribers
65
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
6.6%
LinkedIn Followers
17,843 are following Transgene SA on LinkedIn, up by 1.4% over the last month.
-
LinkedIn Followers
17843
-
Daily Change
0%
-
1 Month Change
1.4%
-
3 Month Change
2.9%
Job Postings
Transgene SA currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Transgene SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Employees
According to LinkedIn, Transgene SA has 209 employees.
-
LinkedIn Employees
209
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.5%
Business Outlook
According to employee reviews, the business outlook among employees at Transgene SA is 40 out of 100 (bearish).
-
Business Outlook
40
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
TNG.PA Financials
TNG.PA Key Metrics
-
Total Revenue
€23K
-
Net Income
-€16.5M
-
Earnings per Share
-€0.16
-
Free cash flow
-€20.1M
-
EBITDA
-€18.5M
-
EBITDA Ratio
-806.261
-
Total Assets
€50.8M
TNG.PA 2-year Revenue & Income
TNG.PA 2-year Free Cash Flow
TNG.PA Technicals
TNG.PA SMA
TNG.PA RSI
FAQ
What's the current price of Transgene SA (TNG.PA) Stock?
The price of an Transgene SA (TNG.PA) share is €0.61.
What's the market cap of Transgene SA?
The current market cap of Transgene SA is 80.5M.
Should I buy or sell TNG.PA?
Transgene SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Transgene SA is better viewed as a hold or accumulate position while waiting for further developments.
Is Transgene SA a good investment?
The current analysis of Transgene SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Transgene SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Transgene SA (TNG.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Transgene SA stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Transgene SA (TNG.PA) that investors often compare it to?
Transgene SA (TNG.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Transgene SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Transgene SA's stock price to be around €0.594 in 2026. Starting from the current price of €0.61, this represents a 2.6% change in price, indicating a neutral outlook for the stock.
How to buy Transgene SA (TNG.PA) Stock?
Transgene SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Transgene SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.